Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953223 · ClinicalTrials.gov registry record
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 144
- Enrollment target
NCT02953223: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT02953223 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02953223 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
To assess the frequency and nature of adverse events in infants fed a free amino acid based infant formula.
Primary Outcome
To assess the frequency and nature of adverse events in infants consuming a free amino acid based infant formula
Interventions
- OTHER Free amino acid infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-01 |
What the finished NCT02953223 record still lists
NCT02953223 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Free amino acid infant formula is the first listed.
NCT02953223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02953223 about?
NCT02953223 is a clinical study titled "A Study to Monitor the Use of an Amino Acid-Based Infant Formula". To assess the frequency and nature of adverse events in infants fed a free amino acid based infant formula.
What is the current status of trial NCT02953223?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2017-01. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02953223?
The interventions under investigation include: Free amino acid infant formula (OTHER).
Who is sponsoring clinical trial NCT02953223?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia